BioAmber Inc. (BIOA) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 79 transactions totaling $42.8M, demonstrating a bullish sentiment with $31.7M in net insider flow. The most recent transaction on Jan 13, 2026 involved a sale of 233,107 shares valued at $4.2M.
No significant insider buying has been recorded for BIOA in the recent period.
No significant insider selling has been recorded for BIOA in the recent period.
Based on recent SEC filings, insider sentiment for BIOA is bullish with an Insider Alignment Score of 87/100 and a net flow of $31.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BioAmber Inc. (BIOA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading BIOA stock, having executed 79 transactions in the past 90 days. The most active insider is Vijay Satyanand Pande (Executive), who has made 5 transactions totaling $16.2M.
Get notified when executives and directors at BIOA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | Fortney Kristen | Executive | Sale | 233,107 | $18.12 | $4.2M | Large |
| Dec 9, 2025 | D. Rubin Paul | Executive | Option Exercise | 18,000 | $6.57 | $118.3K | |
| Dec 9, 2025 | D. Rubin Paul | Executive | Sale | 18,000 | $12.00 | $216.0K | |
| Dec 4, 2025 | D. Rubin Paul | Executive | Sale | 68,897 | $10.19 | $702.1K | Large |
| Dec 4, 2025 | D. Rubin Paul | Executive | Option Exercise | 68,897 | $4.11 | $283.2K | |
| Sep 27, 2024 | Healy James | Executive | Purchase | 11,113 | $18.00 | $200.0K | |
| Sep 27, 2024 | Healy James | Executive | Purchase | 21,814 | $18.00 | $392.7K | |
| Sep 27, 2024 | Healy James | Executive | Purchase | 18,353 | $18.00 | $330.4K | |
| Sep 27, 2024 | Healy James | Executive | Purchase | 26,497 | $18.00 | $476.9K | |
| Sep 27, 2024 | Healy James | Executive | Purchase | 588,888 | $18.00 | $10.6M | Large |
| Sep 27, 2024 | Healy James | Executive | Conversion | 1,638,236 | $N/A | $0 | |
| Sep 27, 2024 | G. Enright Patrick | Executive | Purchase | 400,000 | $18.00 | $7.2M | Large |
| Sep 27, 2024 | G. Enright Patrick | Executive | Conversion | 1,310,589 | $N/A | $0 | |
| Sep 27, 2024 | Satyanand Pande Vijay | Executive | Conversion | 655,294 | $N/A | $0 | |
| Sep 27, 2024 | Satyanand Pande Vijay | Executive | Conversion | 855,972 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 64 | $37.2M | 85.5% |
Sale(S) | 5 | $5.5M | 12.7% |
Exercise(M) | 2 | $401.4K | 0.9% |
Exercise (Options)(X) | 2 | $395.4K | 0.9% |
Conversion(C) | 6 | $0 | 0.0% |
Insiders at BioAmber Inc. are accumulating shares at an accelerated pace. With 18 insiders making 79 transactions totaling $37.2M in purchases versus $5.5M in sales, the net buying activity of $31.7M signals strong executive confidence. Vijay Satyanand Pande (Executive) leads the buying activity with $16.2M in transactions across all time.